RBMX2 Inhibitors
Inhibitors of RBMX2 function through a diverse range of mechanisms, all centered around the disruption of RNA processing and transcription regulation. The protein is crucial for the proper splicing and processing of mRNA, and its activity is closely linked to the transcriptional machinery. By targeting various stages of the RNA lifecycle, from synthesis to splicing, these chemical compounds can effectively reduce the functional activity of RBMX2. For instance, chemicals that bind to RNA polymerase II inhibit the transcription of a broad range of mRNAs, including that of RBMX2. This results in decreased levels of the protein, as its synthesis is directly dependent on the availability of its mRNA.
On the other hand, compounds that target the DNA itself, either by intercalation or by adduct formation, can also impact RBMX2 levels. These chemicals cause structural alterations in the DNA, which can inhibit transcriptional enzymes and lead to the downregulation of gene expression. Furthermore, inhibitors of topoisomerases, enzymes responsible for the unwinding and rewinding of DNA during transcription and replication, can also lead to decreased RBMX2 function. By stabilizing the DNA in an unwound state or causing DNA damage, these inhibitors can obstruct the transcriptional process necessary for RBMX2 mRNA production and subsequent protein synthesis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Triptolide inhibits the transcriptional activity of RNA Polymerase II, which could decrease RBMX2 expression levels by preventing its transcription. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin binds irreversibly to RNA polymerase II, blocking mRNA synthesis. This action could downregulate RBMX2 by inhibiting its mRNA production. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D intercalates into DNA and prevents the transcription of RNA, which could reduce RBMX2 expression by blocking its gene transcription. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB inhibits RNA Polymerase II phosphorylation, leading to the suppression of mRNA synthesis, which could result in lowered levels of RBMX2. | ||||||
ICRF-193 | 21416-68-2 | sc-200889 sc-200889A | 1 mg 5 mg | $341.00 $927.00 | 7 | |
ICRF-193 stabilizes the closed clamp form of DNA topoisomerase II, inhibiting its activity and potentially reducing RBMX2 expression by limiting mRNA splicing and processing. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin inhibits DNA topoisomerase I, leading to DNA damage and potentially impairing RBMX2 function by disrupting the processing of its mRNA. | ||||||
Oxaliplatin | 61825-94-3 | sc-202270 sc-202270A | 5 mg 25 mg | $112.00 $394.00 | 8 | |
Oxaliplatin forms platinum-DNA adducts, which may inhibit transcription and consequently reduce RBMX2 levels by preventing its gene transcription. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
Mitoxantrone intercalates into DNA and inhibits Topoisomerase II, which could decrease RBMX2 expression due to reduced mRNA synthesis and processing. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide inhibits DNA topoisomerase II, which could reduce RBMX2 expression by disrupting its mRNA processing and splicing. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine intercalates into DNA and RNA, which can inhibit DNA and RNA polymerase activity, potentially reducing RBMX2 expression by blocking its transcription. | ||||||